Real Estate Archives - Page 14 of 25

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

September 17, 2025

Viridian Therapeutics Completes Enrollment in REVEAL Clinical Trials, Advances Portfolio

September 15, 2025

Takeda Appoints Rhonda Pacheco to Lead U.S. Business Unit as Julie Kim Prepares for CEO Role

September 11, 2025

THIS WEEK'S STORIES

Synthesize Bio Launches with $10 Million Seed Round to Advance Generative Genomics

September 17, 2025

Brainlab Wins FDA Clearance and Launches Spine Mixed Reality Navigation in the U.S.

September 18, 2025

Colossal Advances Dodo De-Extinction with Breakthrough in Pigeon Germ Cell Science and Secures $120 Million in New Funding

September 17, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Real Estate

Paysign Expands Patient Affordability Business with New 30,000 Square Foot Support Center

C2N Diagnostics Expands St. Louis Headquarters to Support Global Demand for Alzheimer’s Testing

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Facility

Enveric Biosciences Relocates Corporate Headquarters to Cambridge, Massachusetts

Treasury Guidance Extends ITC Window, Safeguards Smaller Solar Projects, Says Solect Energy

Most Read

Hallmark Health Care Solutions Names John Feminella Senior Vice President of Data and AI

Sunflower Therapeutics Reaches First Milestone in HPV Vaccine Collaboration with SK bioscience

Brainlab Wins FDA Clearance and Launches Spine Mixed Reality Navigation in the U.S.

Vertex Secures CASGEVY Reimbursement Agreement in Italy for Beta Thalassemia and Sickle Cell Disease

EDITOR PICKS

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

Viridian Therapeutics Completes Enrollment in REVEAL Clinical Trials, Advances Portfolio

Takeda Appoints Rhonda Pacheco to Lead U.S. Business Unit as Julie Kim Prepares for CEO Role

THIS WEEK'S STORIES

Synthesize Bio Launches with $10 Million Seed Round to Advance Generative Genomics

Brainlab Wins FDA Clearance and Launches Spine Mixed Reality Navigation in the U.S.

Colossal Advances Dodo De-Extinction with Breakthrough in Pigeon Germ Cell Science and Secures $120 Million in New Funding

POPULAR CATEGORY

ABOUT US

FOLLOW US